Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-08-31

FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for a lisinopril and hydrochlorothiazide fixed-dose combination tablet from Lupin Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisinopril and Hydrochlorothiazide (Lisinopril and Hydrochlorothiazide)

Snippet

SUPPL AP for LISINOPRIL AND HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE)